Retirement Systems of Alabama boosted its holdings in Encompass Health Co. (NYSE:EHC – Free Report) by 0.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 278,834 shares of the company’s stock after purchasing an additional 385 shares during the period. Retirement Systems of Alabama’s holdings in Encompass Health were worth $18,604,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. McGlone Suttner Wealth Management Inc. bought a new stake in shares of Encompass Health in the fourth quarter valued at $30,000. GAMMA Investing LLC bought a new stake in shares of Encompass Health in the fourth quarter valued at $33,000. C M Bidwell & Associates Ltd. bought a new stake in shares of Encompass Health in the third quarter valued at $35,000. Headlands Technologies LLC bought a new stake in shares of Encompass Health in the fourth quarter valued at $70,000. Finally, Harvest Fund Management Co. Ltd bought a new stake in shares of Encompass Health in the third quarter valued at $109,000. 97.25% of the stock is currently owned by institutional investors.
Encompass Health Price Performance
Encompass Health stock opened at $83.41 on Wednesday. Encompass Health Co. has a 52 week low of $57.55 and a 52 week high of $85.84. The business has a 50-day simple moving average of $78.64 and a 200 day simple moving average of $71.25. The company has a quick ratio of 1.28, a current ratio of 1.37 and a debt-to-equity ratio of 1.14. The stock has a market cap of $8.35 billion, a price-to-earnings ratio of 22.54, a PEG ratio of 1.31 and a beta of 0.94.
Encompass Health Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were issued a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health’s payout ratio is currently 16.22%.
Analyst Ratings Changes
Several brokerages have issued reports on EHC. Truist Financial boosted their target price on Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a research note on Friday, February 9th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a research note on Wednesday, February 7th. Mizuho boosted their price objective on Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Thursday, April 25th. Royal Bank of Canada reiterated an “outperform” rating and set a $83.00 price objective on shares of Encompass Health in a research note on Friday, February 9th. Finally, Raymond James reiterated a “strong-buy” rating and set a $95.00 price objective (up from $85.00) on shares of Encompass Health in a research note on Friday, April 26th. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Encompass Health has an average rating of “Buy” and an average target price of $88.13.
Check Out Our Latest Research Report on Encompass Health
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Featured Articles
- Five stocks we like better than Encompass Health
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- How to Invest in the Best Canadian Stocks
- Hilton Demonstrates Asset Light is Right for Investors
- 3 Warren Buffett Stocks to Buy Now
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC – Free Report).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.